The Elipse Balloon has been widely available in Europe since 2012, though it is in recent years that it has gained tremendous popularity attributed to the many success stories associated with the Elipse Programme and its safety profile.
Total adverse events reported were less than 2% in over 30,000 Elipse Balloons distributed.
(Data from March 2016 – September 2020)
Premature Deflation 0.44%
Intolerance 0.26%
Small Bowel Obstruction 0.09%
Hyperinflation 0.8%
Dysphagia 0.03%
Gastric Outlet Obstruction 0.03%
Gastric Perforation 0.01%
Incomplete Device Emptying 0.01%
Pancreatitis 0.02%
Gastroparesis 0.01%
Share this page:
The Hayloft
Gawsworth Business Court
Shellow Lane
Gawsworth
CW12 2NX
© 2021 All Rights Reserved
Allure Weightloss Limited trading as Allure Weightloss
Company registered in England and Wales No. 12696475.
Registered address: Rhino Court ,6 Station View, Hazel Grove, Stockport SK7 5ER
* “in rare cases the elipse balloon may require endoscopic or surgical intervention for removal”. ** “Weight loss results and benefits do vary and are different for each individual”
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.